UBS Maintains Neutral on Walgreens Boots Alliance, Lowers Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Caliendo maintains a Neutral rating on Walgreens Boots Alliance (NASDAQ:WBA) but lowers the price target from $22 to $17.
June 24, 2024 | 5:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
UBS analyst Kevin Caliendo maintains a Neutral rating on Walgreens Boots Alliance (NASDAQ:WBA) and lowers the price target from $22 to $17.
The lowered price target from $22 to $17 by UBS suggests a negative outlook on Walgreens Boots Alliance's future performance. This could lead to a short-term decline in the stock price as investors react to the reduced target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100